NEW YORK — In Healio Video Perspective from OSN New York Retina, Andrew A. Moshfeghi, MD, MBA, discusses the utility of dual inhibition therapy for the long-term treatment of diabetic macular edema.
“I believe that faricimab, of all of the available agents, gives us that opportunity insofar as it is blocking not just VEGF, which we all know how well that works, but also Ang 2,” Moshfeghi said.